sb 216763 has been researched along with Fragile X Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allan, AM; Guo, W; Johnson, EB; Murthy, AC; Schaller, EG; Zhang, L; Zhao, X | 1 |
1 other study(ies) available for sb 216763 and Fragile X Syndrome
Article | Year |
---|---|
Inhibition of GSK3β improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome.
Topics: Animals; Disease Models, Animal; Fragile X Mental Retardation Protein; Fragile X Syndrome; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Indoles; Learning; Male; Maleimides; Mice; Mice, Knockout; Nerve Net; Neurogenesis; Neurons; Phosphorylation; Protein Kinase Inhibitors | 2012 |